pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3200 |
Genomic Coordinates | chr22: 30731557 - 30731641 |
Description | Homo sapiens miR-3200 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||
---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3200-3p | ||||||
Sequence | 54| CACCUUGCGCUACUCAGGUCUG |75 | ||||||
Evidence | Experimental | ||||||
Experiments | Illumina | ||||||
SNPs in miRNA |
|
||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | CD55 | ||||||||||||||||||||
Synonyms | CR, CROM, DAF, TC | ||||||||||||||||||||
Description | CD55 molecule (Cromer blood group) | ||||||||||||||||||||
Transcript | NM_000574 | ||||||||||||||||||||
Other Transcripts | NM_001114752 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on CD55 | |||||||||||||||||||||
3'UTR of CD55 (miRNA target sites are highlighted) |
>CD55|NM_000574|3'UTR 1 CCAAAGAAGAGTTAAGAAGAAAATACACACAAGTATACAGACTGTTCCTAGTTTCTTAGACTTATCTGCATATTGGATAA 81 AATAAATGCAATTGTGCTCTTCATTTAGGATGCTTTCATTGTCTTTAAGATGTGTTAGGAATGTCAACAGAGCAAGGAGA 161 AAAAAGGCAGTCCTGGAATCACATTCTTAGCACACCTACACCTCTTGAAAATAGAACAACTTGCAGAATTGAGAGTGATT 241 CCTTTCCTAAAAGTGTAAGAAAGCATAGAGATTTGTTCGTATTTAGAATGGGATCACGAGGAAAAGAGAAGGAAAGTGAT 321 TTTTTTCCACAAGATCTGTAATGTTATTTCCACTTATAAAGGAAATAAAAAATGAAAAACATTATTTGGATATCAAAAGC 401 AAATAAAAACCCAATTCAGTCTCTTCTAAGCAAAATTGCTAAAGAGAGATGAACCACATTATAAAGTAATCTTTGGCTGT 481 AAGGCATTTTCATCTTTCCTTCGGGTTGGCAAAATATTTTAAAGGTAAAACATGCTGGTGAACCAGGGGTGTTGATGGTG 561 ATAAGGGAGGAATATAGAATGAAAGACTGAATCTTCCTTTGTTGCACAAATAGAGTTTGGAAAAAGCCTGTGAAAGGTGT 641 CTTCTTTGACTTAATGTCTTTAAAAGTATCCAGAGATACTACAATATTAACATAAGAAAAGATTATATATTATTTCTGAA 721 TCGAGATGTCCATAGTCAAATTTGTAAATCTTATTCTTTTGTAATATTTATTTATATTTATTTATGACAGTGAACATTCT 801 GATTTTACATGTAAAACAAGAAAAGTTGAAGAAGATATGTGAAGAAAAATGTATTTTTCCTAAATAGAAATAAATGATCC 881 CATTTTTTGGTATCATGTAGTATGTGAAATTTATTCTTAAACGTGACTACTTTATTTCTAAATAAGAAATTCCCTACCTG 961 CTTCCTACAAGCAGTTCAGAATGCCATGCCTTGGTTGTCCTAGTGTGAATAATTTTCAGCTACTTTAAAATTATATTGTA 1041 CTTTCTCAAGCATGTCATATCCTTTCCTATTAGAGTATCTATATTACTTGTTACTGATTTACCTGAAGGCAATCTGATTA 1121 ATTTCTAGGTTTTTACCATATTCTTGTCATCTTGCCAATTACATTTTAAGTGTTAGACTAGACTAAGATGTACTAGTTGT 1201 ATAGAATATAACTAGATTTATTATGGCAATGTTTATTTTGTCATTTTGCTTCATCTGTTTTGTTGTTGAAGTACTTTAAA 1281 TTTCATACGTTCATGGCATTTCACTGTAAAGACTTTAATGTGTATTTCTTAAAATAAAACTTTTTTTCCTCCTTAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
miRNA:Target | ---- | |||||||||
Validation Method |
|
|||||||||
Conditions | HEK293S | |||||||||
Location of target site | 3'UTR | |||||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | |||||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1084065. RNA binding protein: AGO2. Condition:CLIP_emetine_AbnovaAb
... - Karginov FV; Hannon GJ, 2013, Genes & development. |
|||||||||
miRNA-target interactions (Provided by authors) |
|
|||||||||
Article |
- Karginov FV; Hannon GJ - Genes & development, 2013
When adapting to environmental stress, cells attenuate and reprogram their translational output. In part, these altered translation profiles are established through changes in the interactions between RNA-binding proteins and mRNAs. The Argonaute 2 (Ago2)/microRNA (miRNA) machinery has been shown to participate in stress-induced translational up-regulation of a particular mRNA, CAT-1; however, a detailed, transcriptome-wide understanding of the involvement of Ago2 in the process has been lacking. Here, we profiled the overall changes in Ago2-mRNA interactions upon arsenite stress by cross-linking immunoprecipitation (CLIP) followed by high-throughput sequencing (CLIP-seq). Ago2 displayed a significant remodeling of its transcript occupancy, with the majority of 3' untranslated region (UTR) and coding sequence (CDS) sites exhibiting stronger interaction. Interestingly, target sites that were destined for release from Ago2 upon stress were depleted in miRNA complementarity signatures, suggesting an alternative mode of interaction. To compare the changes in Ago2-binding patterns across transcripts with changes in their translational states, we measured mRNA profiles on ribosome/polysome gradients by RNA sequencing (RNA-seq). Increased Ago2 occupancy correlated with stronger repression of translation for those mRNAs, as evidenced by a shift toward lighter gradient fractions upon stress, while release of Ago2 was associated with the limited number of transcripts that remained translated. Taken together, these data point to a role for Ago2 and the mammalian miRNAs in mediating the translational component of the stress response.
LinkOut: [PMID: 23824327]
|
CLIP-seq Support 1 for dataset GSM1084065 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_emetine_AbnovaAb |
Location of target site | ENST00000314754.8 | 3UTR | AUAGGUGGAAAUGAUGGAGAAGAUGGGAAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
35 hsa-miR-3200-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT052815 | CDC37 | cell division cycle 37 | 1 | 1 | ||||||||
MIRT052816 | ATP6V1E2 | ATPase H+ transporting V1 subunit E2 | 1 | 1 | ||||||||
MIRT052817 | MCM3AP | minichromosome maintenance complex component 3 associated protein | 1 | 1 | ||||||||
MIRT052818 | NSUN4 | NOP2/Sun RNA methyltransferase family member 4 | 1 | 1 | ||||||||
MIRT052819 | EXOC4 | exocyst complex component 4 | 1 | 1 | ||||||||
MIRT052820 | DDB1 | damage specific DNA binding protein 1 | 1 | 1 | ||||||||
MIRT052821 | CAD | carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | 1 | 1 | ||||||||
MIRT052822 | RPL23 | ribosomal protein L23 | 1 | 1 | ||||||||
MIRT052823 | TPT1 | tumor protein, translationally-controlled 1 | 1 | 1 | ||||||||
MIRT052824 | RPSA | ribosomal protein SA | 1 | 1 | ||||||||
MIRT052825 | PPIA | peptidylprolyl isomerase A | 1 | 1 | ||||||||
MIRT052826 | SSRP1 | structure specific recognition protein 1 | 1 | 1 | ||||||||
MIRT052827 | STX2 | syntaxin 2 | 1 | 1 | ||||||||
MIRT095464 | PURA | purine rich element binding protein A | 2 | 4 | ||||||||
MIRT325192 | PSAT1 | phosphoserine aminotransferase 1 | 2 | 2 | ||||||||
MIRT447293 | ZNF562 | zinc finger protein 562 | 2 | 2 | ||||||||
MIRT450360 | GRAMD3 | GRAM domain containing 2B | 2 | 2 | ||||||||
MIRT482917 | ZNF845 | zinc finger protein 845 | 2 | 2 | ||||||||
MIRT498302 | DCAF8 | DDB1 and CUL4 associated factor 8 | 2 | 2 | ||||||||
MIRT500041 | PABPC3 | poly(A) binding protein cytoplasmic 3 | 2 | 8 | ||||||||
MIRT541475 | ARHGAP12 | Rho GTPase activating protein 12 | 2 | 12 | ||||||||
MIRT556269 | MAPK6 | mitogen-activated protein kinase 6 | 2 | 2 | ||||||||
MIRT565440 | SURF4 | surfeit 4 | 2 | 2 | ||||||||
MIRT573386 | GPR20 | G protein-coupled receptor 20 | 2 | 2 | ||||||||
MIRT627911 | OCIAD2 | OCIA domain containing 2 | 2 | 2 | ||||||||
MIRT633645 | SKAP2 | src kinase associated phosphoprotein 2 | 2 | 2 | ||||||||
MIRT643472 | PDK3 | pyruvate dehydrogenase kinase 3 | 2 | 2 | ||||||||
MIRT646284 | GALNT2 | polypeptide N-acetylgalactosaminyltransferase 2 | 2 | 2 | ||||||||
MIRT647889 | CD55 | CD55 molecule (Cromer blood group) | 2 | 2 | ||||||||
MIRT664712 | EIF4G3 | eukaryotic translation initiation factor 4 gamma 3 | 2 | 2 | ||||||||
MIRT668135 | GINS2 | GINS complex subunit 2 | 2 | 2 | ||||||||
MIRT686490 | TRIOBP | TRIO and F-actin binding protein | 2 | 2 | ||||||||
MIRT709525 | IGF2 | insulin like growth factor 2 | 2 | 2 | ||||||||
MIRT722252 | NTMT1 | N-terminal Xaa-Pro-Lys N-methyltransferase 1 | 2 | 2 | ||||||||
MIRT755478 | CAMK2A | calcium/calmodulin dependent protein kinase II alpha | 4 | 1 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|